The morphometric characteristic of bone marrow megakaryocyte clusters in Ph-negative JAK2 mutated chronic myeloproliferative neoplasms

被引：0
|
作者：
Krivolapov, Y. [1 ]
Asaulenko, Z. [1 ]
Spiridonov, I. [1 ]
Selent'eva, A. [1 ]
Polushkina, L. [1 ]
机构：
[1] SZGMU, St Petersburg, Russia
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-08-024
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [31] Clinical significance of the quantification of JAK2V617F allele burden in classical Ph-negative myeloproliferative neoplasms
    Kerguelen Fuentes, Ana Esther
    Hernandez-Maraver, Dolores
    Lombardia, Luis
    Canales Albendea, Miguel Angel
    Rodriguez de la Rua, Ana
    MEDICINA CLINICA, 2012, 139 (09): : 373 - 378
  • [32] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Edahiro, Yoko
    Morishita, Soji
    Takahashi, Kochi
    Hironaka, Yumi
    Yahata, Yuriko
    Sunami, Yoshitaka
    Shirane, Shuichi
    Tsutsui, Miyuki
    Noguchi, Masaaki
    Koike, Michiaki
    Imai, Kiyotoshi
    Kirito, Keita
    Noda, Naohiro
    Sekiguchi, Yuji
    Tsuneda, Satoshi
    Ohsaka, Akimichi
    Araki, Marito
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 625 - 634
  • [33] The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms
    Soler, G.
    Bernal-Vicente, A.
    Anton, A. I.
    Torregrosa, J. M.
    Caparros-Perez, E.
    Sanchez-Serrano, I.
    Martinez-Perez, A.
    Sanchez-Vega, B.
    Vicente, V.
    Ferrer-Marin, F.
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 789 - 794
  • [34] The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms
    G. Soler
    A. Bernal-Vicente
    A. I. Antón
    J. M. Torregrosa
    E. Caparrós-Pérez
    I. Sánchez-Serrano
    A. Martínez-Pérez
    B. Sánchez-Vega
    V. Vicente
    F. Ferrer-Marin
    Annals of Hematology, 2015, 94 : 789 - 794
  • [35] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Yoko Edahiro
    Soji Morishita
    Kochi Takahashi
    Yumi Hironaka
    Yuriko Yahata
    Yoshitaka Sunami
    Shuichi Shirane
    Miyuki Tsutsui
    Masaaki Noguchi
    Michiaki Koike
    Kiyotoshi Imai
    Keita Kirito
    Naohiro Noda
    Yuji Sekiguchi
    Satoshi Tsuneda
    Akimichi Ohsaka
    Marito Araki
    Norio Komatsu
    International Journal of Hematology, 2014, 99 : 625 - 634
  • [36] Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
    Grzegorz Helbig
    Medical Oncology, 2018, 35
  • [37] Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors
    Helbig, Grzegorz
    MEDICAL ONCOLOGY, 2018, 35 (09)
  • [38] Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
    Moia, Riccardo
    Cittone, Micol Giulia
    Boggione, Paola
    Manfredi, Giulia Francesca
    Favini, Chiara
    Awikeh, Bassel
    Pedrinelli, Anita Rebecca
    Mahmoud, Abdurraouf Mokhtar
    Nicolosi, Maura
    Bellan, Mattia
    Sainaghi, Pier Paolo
    Pirisi, Mario
    Gaidano, Gianluca
    Patriarca, Andrea
    Rigamonti, Cristina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] STIFFER SPLEEN PREDICTS HIGHER BONE MARROW FIBROSIS AND HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
    Moia, R.
    Boggione, P.
    Cittone, M.
    Manfredi, G.
    Favini, C.
    Awikeh, B.
    Pirisi, M.
    Gaidano, G.
    Patriarca, A.
    Rigamonti, C.
    HAEMATOLOGICA, 2021, 106 (10) : 82 - 83
  • [40] Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms
    Hu, Linhui
    Pu, Lianfang
    Ding, Yangyang
    Li, Manman
    Cabanero, Michael
    Xie, Jingxin
    Zhou, Dejun
    Yang, Dongdong
    Zhang, Cui
    Wang, Huiping
    Zhai, Zhimin
    Ru, Xiang
    Li, Jingrong
    Xiong, Shudao
    HEMATOLOGY, 2017, 22 (06) : 354 - 360
12345